Comparative Effectiveness of Switching From First-Generation Basal Insulin to Glargine 300 U/ml or Degludec 100 U/ml in Type 1 Diabetes: The RESTORE-1 Study

Podobne zapisy

• In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes
  od: Schiavon, Michele, i wsp.
  Wydane: (2020)
• Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml
  od: Steinstraesser, A, i wsp.
  Wydane: (2014)
• Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial
  od: Bolli, Geremia B., i wsp.
  Wydane: (2021)
• Conversion from insulin glargine U-100 to insulin glargine U-300 or insulin degludec and the impact on dosage requirements
  od: Pearson, Scott M., i wsp.
  Wydane: (2018)
• InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring—Study Design
  od: Battelino, Tadej, i wsp.
  Wydane: (2020)